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ABSTRACT
Background: There is a clinical need for biomimetic corneas that are as effective, preferably superior, to cadaveric
donor tissue. Decellularized tissues are advantageous compared to synthetic or semi-synthetic engineered
tissues in that the native matrix ultrastructure and intrinsic biological cues including growth factors, cytokines
and glycosaminoglycans may be retained. However, there is currently no reliable, standardized human corneal
decellularization protocol.
Methods: Corneal eye-bank tissue unsuitable for transplantation was utilized to systematically compare
commonly used decellularization protocols. Hypertonic sodium chloride; an ionic reagent, sodium dodecyl
sulphate; a non-ionic detergent, tert-octylphenol polyoxyethylene (Triton-X); enzymatic disaggregation using
Dispase; mechanical agitation; and the use of nucleases were investigated. Decellularization efficacy,
specifically for human corneal tissue, was extensively evaluated. Removal of detectable cellular material was
evidenced by histological, immunofluorescence and biochemical assays. Preservation of macroscopic tissue
transparency and light transmittance was evaluated. Retention of corneal architecture, collagen and
glycosaminoglycans was assessed via histological, immunofluorescence and quantitative analysis.
Biocompatibility of the resulting scaffolds was assessed using cell proliferation assays.
Results: None of the decellularization protocols investigated successfully removed 100% of cellular components.
The techniques with the least residual cellular material were most structurally compromised. Biochemical
analysis of glycosaminoglycans demonstrated the stripping effects of the decellularization procedures.
Conclusion: The ability to utilize, reprocess and regenerate tissues deemed ‘‘unsuitable’’ for transplantation
allows us to salvage valuable tissue. Reprocessing the tissue has the potential to have a considerable impact on
addressing the problems associated with cadaveric donor shortage. Patients would directly benefit by accessing
greater numbers of corneal grafts and health authorities would fulfill their responsibility for the delivery of
effective corneal reconstruction to alleviate corneal blindness. However, in order to progress, we may need to
take a step back to establish a ‘‘decellularization’’ criterion; which should balance effective removal of immune
reactive material with maintenance of tissue functionality.
Keywords: Biocompatibility, collagen, corneal decellularization, glycosaminoglycans, residual cellular material,
stromal transparency
INTRODUCTION
There are approximately 1.5 million cases of corneal
blindness diagnosed annually and 10 million
untreated patients worldwide.1–6 Presently, there are
insufficient numbers of suitable corneas for allograft-
ing to meet demand, particularly in Africa and Asia
predominantly due to cultural, religious, logistical
and technical issues.7,8 An ageing population, increas-
ing worldwide trends for refractive surgery, and the
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relative short shelf-life of suitable corneas9 further
compound the issue. Where supply is not an issue, the
quality of cadaveric tissue is variable, and despite its
‘‘immune privileged’’ status,10–12 1 in 6 full-thickness
allografts experience some degree of rejection,13 usu-
ally caused by immunological responses to epithelial
or endothelial antigens. This highlights the compel-
ling need to develop procedures to manufacture
reliable, reproducible biomimetic corneas as effective,
preferably superior to cadaveric tissue for clinical
translation.
Despite huge advances in tissue engineering, there
is yet to be a successful biological or synthetic
engineered corneal tissue in routine clinical practice.
Often, they do not meet the clinical demand for long-
term biocompatibility and regenerative capacity,
transparency and sufficient mechanical strength.14
Fundamental challenges include: replication of the
unique tissue structure, complete with intrinsic bio-
logical and topographical cues and the maintenance
of healthy corneal cells. The lack of nanoscale tissue
architecture in tissue engineered constructs often
results in a construct with compromised biomechan-
ical properties, a lack of tensile strength, tissue
curvature, reduced optical properties and ultimately
rejection following implantation.
In western countries, such as the UK, many
harvested corneas are rejected for transplantation as
they fail to meet the biological screening criteria (44%,
1846 corneas15). In most cases, the tissues are struc-
turally intact, so the ability to reprocess these tissues
as a clinically relevant product could have consider-
able impact on addressing shortages. Presently, few
studies investigate the use of human tissue,16,17 and
there is currently no standardized decellularization
protocol specifically for human corneal tissue.
Comparatively, xenogeneic matrices have been com-
prehensively investigated.8,18–26 Unfortunately, inter-
species differences are a prevalent problem leading to
graft failure.27 Furthermore, xenogeneic materials face
many more immunological and regulatory barriers
compared to human tissue. Thus, utilizing human
tissue may be a simpler solution. To realize this, the
development of appropriate decellularization meth-
ods is of utmost importance.
Commonly employed methods of decellularization
include the use of detergents, including ionic, non-
ionic and zwitter-ionic detergents and hypertonic
solutions.14,22,28 Extensive reviews of decellularization
methods can be found elsewhere.29–32 Extensive use of
decellularizing reagents coupled with varying, often
laborious, protocols make evaluating existing decel-
lularization techniques and their applicability to
human corneal applications, difficult to compare.
Furthermore, due to cost and methodological com-
plexity implications, many techniques are not up-
scalable from a manufacturing point of view, a factor
which needs to be considered when designing
clinically viable tissues. In addition, published corneal
decellularization protocols often lack full character-
ization of the decellularized tissue, relying largely on
qualitative data, resulting in misleading and/or con-
flicting results.
The aim of this article is to provide a systematic
comparison of commonly used decellularization
methods including: hypertonic sodium chloride
(NaCl); an ionic reagent, sodium dodecyl sulphate
(SDS); a non-ionic detergent, tert-octylphenol polyox-
yethylene (Triton-X); enzymatic disaggregation using
Dispase, mechanical agitation; and nucleases. Human
corneas are extensively evaluated using both qualita-
tive and quantitative analysis to ascertain if an
appropriate balance between removal of cellular
material while maintaining the corneal structure and
important biological cues is achievable.
MATERIALS AND METHODS
Human Cornea Decellularization
All reagents were purchased from Sigma-Aldrich,
Poole, UK, unless otherwise stated. Corneas unsuit-
able for transplantation were utilized in this study.
Often the corneas have been stored for periods
exceeding 2 months. Human tissue use was approved
by the local ethics research committee (NRES
Committee East Midlands-Nottingham 1, 07/H0403/
140), in accordance with the tenants of the declaration
of Helsinki, following consent from the donors or
their relatives. Excess scleral tissue was removed
aseptically and the corneas were washed in 10 mL
phosphate buffered saline (PBS, 3 5 min) at room
temperature (RT).
The corneas were initially decellularized using
10 mL of the following reagents; (i) hypertonic solu-
tion, 1.5 M NaCl in PBS; (ii) ionic-detergent, 0.5% w/v
SDS in PBS (Amersham BioScience, Bucks, UK); or (iii)
non-ionic detergent, 1% w/v Triton-X100 in PBS. All
decellularization solutions contained 1 complete
protease inhibitors (Roche, Hertfordshire, UK) used
according to the manufacturer’s instructions. All
corneas were incubated at 4 C with agitation for
24 h (SRT6 roller mixer, Stuart, SLS, Yorkshire, UK)
followed by washing in 10 mL PBS (2 24 h with
agitation). Three ‘‘control’’ corneas were investigated:
(i) Stromal controls were prepared by overnight
treatment at 4 C with 2.4 U/mL Dispase II
(CellnTec, Bern, Switzerland) before removing the
epithelium and endothelium using sharp-point for-
ceps; (ii) agitated controls were subjected to mechan-
ical agitation in 10 mL PBS; (iii) complete controls
were simply stored under 10 mL PBS at RT (changed
daily) for the duration of the experiment. All the
aforementioned conditions were repeated, with an
additional nuclease treatment as previously
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described.16 Briefly, corneas were treated with 10 mL
5 U/mL DNase and 5 U/mL RNase for 48 h under
agitation (2 24 h). The corneas were then washed
in 10 mL PBS for 72 h, with agitation, with PBS
changed every 24 h.
Macroscopic Evaluation and Light
Transmittance
Corneal tissues was appraised macroscopically pre-
and post-treatment. Digital images were recorded
(Samsung SM-G357FZ). Light transmittance was
evaluated using a fluorescent spectrophotometer
(Tecan Infinite 200 PRO). Absorbance was measured
at 480 nm and 21 readings were taken across each
cornea (n= 5); a mean value was calculated account-
ing for tissue heterogeneity. Data were analyzed as a
mean percentage loss of transparency compared to the
tissue transparency pre-treatment.
Histology and Immunohistochemistry
Harris Hematoxylin (VWR International, Germany)
and 1% eosin (RAL Diagnostics, France) was used to
evaluate tissue architecture. Samples were stained
with 1% Alcian blue 8GX for 5 min followed by
washing in diH2O to visualize glycosaminoglycan
(GAG) content. Samples were examined using an
inverted microscope (Leica, DM-1RB, Leica, Milton
Keynes, UK).
Rehydrated tissue sections were also subjected to
blocking with bovine serum albumin (BSA, 1% w/v in
PBS) for 60 min. BSA was removed before staining
with either rabbit anti-collagen-I polyclonal antibody
(Abcam, Cambridge, UK) to evaluate tissue architec-
ture; or mouse anti-human keratan-sulfate monoclo-
nal antibody (Clone: EFG-11 (1A3), AbD Serotec,
Oxford, UK) to assess maintenance/disruption of
keratan sulfate (1:200 dilution in 1% BSA) overnight
at 4 C. The samples were washed (3 5 min) in PBS.
Alexa fluor 488 donkey anti-rabbit IgG or Alexa fluor
594 donkey anti-mouse IgG (Life Technologies,
Paisley UK) were used to fluorescently label the
samples (1:200 dilution in 1% BSA) for 1 h at RT.
Collagen-I stained samples were counterstained with
40, 6-diamidino-2-phenylindole (DAPI) (1:500), and
examined using an upright fluorescent microscope
(Olympus BX51, Southend-on-Sea, UK).
DNA Quantification
Corneal tissues were processed for DNA extraction by
desiccating the tissue (Christ-Alpha 1-4 LSC Freeze
Dryer), and then recording the dry mass of each
sample. DNA was extracted and purified using a
DNeasy Blood and Tissue Kit (Qiagen, Crawley, UK)
according to the manufacturer’s instructions. The
resulting contaminant-free bound DNA was eluted
into 20 mL buffer solution prior to spectroscopic
analysis using a Quant-iTTM PicoGreen dsDNA
Assay Kit (Molecular Probes, Cambridge, UK) accord-
ing to the manufacturer’s instructions. Fluorescence
was measured at excitation wavelength of 480 nm and
emission wavelength of 520 nm. Residual DNA was
normalized to the dry weight of the tissue. Five
corneas per treatment were analyzed, all measure-
ments were performed in triplicate.
Collagen Quantification
The collagen content of decellularized corneas was
determined used a SircolTM soluble collagen assay
(Biocolor Ltd, Belfast, UK) according to the manufac-
turer’s protocol. Corneas were desiccated and their
dry weight recorded, prior to digestion for 16 days at
RT in pepsin extraction reagent (10 mg/mL in 0.5 M
acetic acid). Digested samples were added to 1 mL
SircolTM dye reagent and mechanically agitated for
30 min, followed by centrifugation. The pellet was
washed in 750 mL acid salt wash reagent prior to
centrifugation. Alkali reagent (250mL) released the
collagen-bound dye into solution, 200 mL was added
to individual wells of a clear 96-well plate (Nunc,
ThermoScientific, Runcorn, UK). Absorbance was
measured at wavelength 555 nm. Five corneas per
treatment were analyzed. Collagen values were
calculated by comparing the samples to a standard
curve. Data is represented as a percentage of collagen
per cornea dry weight. Non-nuclease treated corneas
were omitted from these experiments.
Sulfated Glycosaminoglycan Quantification
The sulfated GAG (sGAG) content of decellularized
corneas was determined using a 1,9-dimethyl methy-
lene blue (DMMB) assay (Biocolor Ltd., Belfast, UK)
according to the manufacturer’s protocol. Corneas
were desiccated and their mass recorded, prior to
digestion for 3 h at 65 C in papain extraction reagent
(125mg/mL papain in 0.2 M sodium phosphate buffer,
5 mM EDTA disodium salt, 10 mM cysteine hydro-
chloride, pH 6.4) as previously described.33 Digested
sample (16 mL in 84 mL RNase-free water) was added
to 1 mL 1,9-DMMB and mechanically agitated for
30 min to form a precipitate sGAG-dye complex
before being centrifuged. Five corneas per treatment
were analyzed, all sample measurements were per-
formed in duplicate. sGAG values were calculated by
comparing the sample values to a standard curve.
sGAG content was adjusted for dry weight and
normalized for blank assay controls.
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Scaffold Biocompatibility
Corneal stromal cells (CSC) were cultured in the
presence of decellularized and control corneas. CSC
were isolated from adult human corneal rims as
previously described.34 CSC were cultured in cell
culture flasks containing M199 medium supple-
mented with 2% (v/v) heat-inactivated fetal bovine
serum (Fisher Scientific, UK), 0.02 mg/mL gentamicin,
0.5 ng/mL amphotericin B (combination, Gibco,
Invitrogen, Paisley, UK) and 1.59 mM L-glutamine.
0.1106 third passage CSC per well were seeded into
12-well companion plates (BD, Falcon, Franklin Lakes,
NJ) and cultured for 24 h under 1 mL media. Corneal
tissues were aseptically dissected into small pieces
and placed onto sterile 12-well cell culture insert
dishes (pore size 0.4 mm; BD, Falcon) above the CSC.
CSC were also cultured alone (cellular control), and
control media collected.
Negative controls whereby 0.5% w/v SDS in media
was added to the stromal cells were assessed.
Cell proliferation was assessed using a
PrestoBlueTM cell viability assay (Molecular Probes,
Invitrogen, UK) according to the manufacturer’s
instructions. Cell viability was assessed at 0, 3, 7, 10
and 14 days. Fluorescence was measured at an
excitation wavelength of 560 nm and emission wave-
length of 590 nm. Five corneas per treatment were
analyzed, all measurements were performed in trip-
licate. Non-nuclease treated corneas were omitted
from these experiments.
Statistical Analysis
Statistical analysis was performed using GraphPad
Prism software (GraphPad Software Inc., San Diego,
CA). Data is represented as mean ± standard devi-
ation. The statistical differences were evaluated
by either one-way or two-way ANOVA, followed
by Tukey’s or Bonferroni’s multiple comparisons tests.
Statistical significance was indicated at four levels:
*p 0.05, **p 0.01, ***p 0.001, ***p 0.0001.
RESULTS
Corneal Transparency and Light
Transmittance
Macroscopic tissue evaluation suggested that mech-
anical agitation and NaCl did not affect transparency
(Figure 1Aix–x). Triton-X-treated corneas experienced
some tissue clouding (Figure 1Axii), but stromal
controls (Figure 1Aiii) and SDS corneas (Figure
1Axi) appeared the most cloudy/opaque following
decellularization. Irrespective of the initial
decellularization treatment, all nuclease treated tis-
sues were cloudy/opaque (Figure 1Axiii–xviii).
Spectroscopic analysis demonstrated no significant
difference in transparency prior to decellularization
(Figure 1B). Following decellularization, spectroscopic
analysis validated macroscopic evaluations confirm-
ing that mechanical agitation and NaCl had no
significant effect on transparency compared to the
complete controls. Triton-X had no significant effect
on transparency despite macroscopic evaluations
indicating opacities. Stromal controls had significantly
reduced transparency compared to agitated controls
(p 0.05), NaCl (p 0.05) and Triton-X-treated corneas
(p 0.05). SDS-treated corneas had most significant
loss of transparency compared to all other groups
(p 0.001).
Following nuclease treatment, all groups experi-
enced a significant reduction in transparency (p 0.01
for stromal controls and NaCl; p 0.05 for agitated
controls and Triton-X-treated corneas; p 0.001 for
SDS-treated corneas).
Collagen Structure and Integrity
Hematoxylin/eosin histological and collagen-I immu-
nohistochemical staining revealed changes to the
stromal architecture following decellularization
(Figure 2Ai–iv and Bi–iv). All treatments disrupted
the lamellae structure, particularly in the posterior
stroma. SDS caused greatest disruption, demonstrated
by increased interfibrillar spacing and tissue voids
(Figure 2Av and Bv). Although disruption was
observed in the stromal controls (Figure 2Bii), it
was not to the extent of corneas treated with
decellularizing reagents. Minimal disruption was
observed in agitated controls (Figure 2Aiii and Biii),
although the epithelium and endothelium were absent.
The addition of nucleases caused subtle interfibrillar
disruption (Figure 2Avii–xii and Bvii–xii), most appar-
ent in stromal controls (Figure 2Bviii), agitated controls
(Figure 2Bix) and SDS-treated corneas (Figure 2A xi
and Bxi). Corneas were also dissected upon arrival into
the laboratory (Fresh) and compared to the control
tissues (Figure 2E). PBS had no apparent effect on the
tissue structure.
Residual DNA Staining and Quantification
DAPI staining revealed that all initial decellulariza-
tion treatments failed to eradicate nuclear material
(Figure 3Ai–iv). Following nuclease treatment DAPI
staining was significantly reduced (Figure 3Avii–xii);
although still detectable in the complete control
(Figure 3Avii), agitated control (Figure 3Axi) and
NaCl-treated corneas (Figure 3Ax).
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PicoGreen spectroscopic analysis was used to
quantitatively evaluate residual DNA. All corneas
demonstrated lower DNA content than the complete
control (Figure 3B). SDS was most effective at
removing DNA (approximately 56%) and was
significantly lower compared to all other control/
treated corneas (p 0.05). Triton-X removed approxi-
mately 23% and NaCl removed approximately 19% of
DNA. Residual DNA in all control corneas was not
significantly different from the complete controls.
FIGURE 1 (A) Macroscopic evaluation of corneal tissue transparency following decellularization treatments and nuclease treatments,
scale bar = 1 cm. (B) Quantitative analysis of loss of light transmittance following decellularization and nuclease treatments, n= 5. Data
represented as the mean value ± the calculated SD. *p 0.05, **p 0.01, ***p 0.001, when comparing the complete control corneas to
decellularized tissues, stromal and agitated controls pre- and post-nuclease treatment.
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Following nuclease treatment all corneas, irrespect-
ive of the initial decellularization treatment, had
significantly lower residual DNA (p 0.0001) than
non-nuclease treated corneas (Figure 3D). All
nuclease-treated corneas, with the exception of the
agitated controls had significantly less residual DNA
(p 0.01) than the nuclease-treated complete controls
(Figure 3C). Nuclease treatment was most successful
FIGURE 2 (A) Haematoxylin/Eosin staining of corneal sections after decellularization treatments (i-vi) and following an additional
nuclease treatment (vii-xii); scale bar = 100 mm. The images demonstrate the disruptive nature of SDS in particular on the corneal
collagen architecture. (B) Collagen-I and DAPI staining of corneal sections following decellularization treatments (i-vi) and following
an additional nuclease treatment (vii-xii), scale bar = 50mm. (C) Alcian blue staining of corneal sections after decellularization
treatments (i-vi) and following an additional nuclease treatment (vii-xii); scale bar = 100 mm. The images demonstrate a decrease in
GAG content following decellularization treatments. (D) KS-GAG immunohistochemical staining demonstrates KS-GAG distribution
in corneas following decellularization treatments (i-vi) and following an additional nuclease treatment (vii-xii), scale bar = 50 mm. (E)
Comparative staining of ‘‘freshly’’dissected corneal tissue, demonstrating that submersion in PBS (complete control) does not have an
effect on tissue structure, cellular and glycosaminoglycan content and distribution.
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in SDS (98.3% DNA removed) and Triton-X (98.0%
DNA removed) decellularized corneas; both had
significantly less DNA remaining than the stromal
controls (p 0.01) and NaCl-treated corneas (p 0.05).
Collagen Quantification
The SircolTM collagen assay revealed that the different
decellularization procedures had no significant effect
on collagen content compared to the control corneas
(Figure 4A). All corneas had an average dry weight of
16.2 mg and a collagen dry weight of 11.5 mg, which
equates to 70.8% collagen comprising the total dry
weight of the cornea.
sGAG Content as a Marker of the Stripping
Effects of Decellularization
The DMMB assay revealed that all decellularization
treatments reduced sGAG content. The removal of the
epithelium and endothelium in the stromal controls
and mechanical agitation alone had no significant
effect on sGAG content (Figure 4B). sGAGs depletion
was most apparent in SDS-treated corneas (470%
sGAGs removed), with the reduction in sGAGs being
significantly greater compared to all controls
(p 0.0001 compared to complete and stromal con-
trols; p 0,001 compared to agitated controls); NaCl
(p 0.05) and Triton-X-treated corneas (p 0.01).
NaCl-treated corneas had the second greatest reduc-
tion in sGAGs compared to control corneas (p 0.001
compared to complete controls; p 0.01 compared to
stromal and agitated controls), with 445% sGAG
reduction. There was no significant difference when
comparing sGAGs in NaCl corneas with Triton-X
corneas. Triton-X corneas experienced approximately
40% depletion in sGAGs, which was significantly less
than all control corneas (p 0.01). Although sGAG
content in the stromal control, agitated control and
Triton-X corneas appeared to be slightly lower fol-
lowing nuclease treatment, the differences were not
significant.
FIGURE 3 (A) DAPI staining of nuclear material demonstrated that initial decellularization treatments fail to completely remove
nuclear material (i–vi), nuclease treated corneas were observed to have significantly less positive DAPI staining (vii–xii), scale
bar = 50 mm. (B) Quantification of residual DNA following decellularization treatments. (C) Quantification of residual DNA following
decellularization with an additional nuclease treatment. (D) A direct comparison of non-nuclease treated corneas versus nuclease
treated corneas, n= 5. Data represented as the mean value ± the calculated SD. *p 0.05, **p 0.01, ***p 0.001.
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Alcian blue histological staining validated the
diminution in GAG content (Figure 2Ci–xiii), with a
significant decrease in Alcian blue saturation in all
decellularized corneas, irrespective of the treatment,
compared to the complete, stromal and agitated
control corneas (Figure 2Ci–vi). Alcian blue staining
was least in SDS corneas (Figure 2Cv). There was no
apparent effect on Alcian blue staining following
treatment with nucleases (Figure 2Cvii–xiii).
Immunohistochemical staining of all control cor-
neas demonstrated KS-GAGs distributed in thin
bands running in parallel between the collagen
fibers (Figure 2Di–iii and Dvii–ix). It was revealed in
corneas treated with NaCl, SDS and Triton-X that not
only was KS-GAG staining reduced, but the
distribution of the KS-GAGs was significantly dis-
rupted (Figure 2Div–vi and Dx–xviii). Nuclease treat-
ment had no apparent effect of KS-GAG staining.
Scaffold Biocompatibility
No cellular outgrowth from the corneal tissues onto
the transwell inserts was observed. Cell proliferation
was limited to the monolayer of CSC cultured in the
companion plate. PrestoBlueTM analysis at day 0
revealed no significant difference in proliferation
between groups (Figure 5). CSC cultured in the
presence of 0.5% w/v SDS (negative controls) lysed
within minutes, and no proliferation occurred.
FIGURE 4 (A) Quantification of collagen content following decellularization with nucleases. The different decellularization protocols
had no effect on collagen concentration. (B) Quantification of sGAG following initial decellularization treatments and decellularization
with an additional nuclease treatment n= 5. Data represented as the mean value ± the calculated SD. The additional nuclease treatment
did not cause a significant reduction in s-GAG content.
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Following 3, 7, 10 and 14 days cells cultured with SDS-
treated tissue with nucleases proliferated significantly
less than all comparative samples (p 0.000, Figure
5B). Following 3 days, there was no significant
difference in proliferation when comparing the cellu-
lar controls to all control corneas and the NaCl and
Triton-X with nuclease treated corneas. However,
following 7 days CSC cultured with tissues treated
with Triton-X with nucleases proliferated significantly
less than CSC cultured with the complete control,
complete control with nucleases, stromal control with
nucleases and agitated control corneas (p 0.05).
There was no significant difference in proliferation
when comparing CSC cultured with NaCl-treated
corneas with nucleases, to Triton-X-treated corneas
with nucleases or the cell control cultured without
corneal tissue.
Following 10 days, proliferation was significantly
lower in cells cultured with tissues that had been
decellularized using NaCl with nucleases, Triton-X
with nucleases and the cellular control, when com-
pared to CSC cultured with the complete control
tissue, complete control with nucleases, stromal con-
trol with nucleases and the agitated control with
nucleases. This trend was repeated at 14 days. In
general, CSC cultured with control tissues, prolifer-
ated more than CSC cultured without corneal tissue
and the decellularized tissue. Corneas treated with
SDS with nucleases had the most antagonistic effect
on proliferation.
DISCUSSION
The principal aim of any decellularization procedure
is to reduce the likelihood of host rejection or
immunological response upon transplantation, while
maintaining the structural integrity and functional
properties of the ECM.29,31,35,36 Often decellularization
techniques aim to completely eradicate cellular and
antigen material, including lipid membranes, mem-
brane associated antigens and soluble proteins.14,30,37
However, such protocols inevitably cause tissue dis-
ruption and stripping of intrinsic biological cues.
Likewise, techniques which maintain the ECM ultra-
structure are likely to leave cellular artifacts and
residual antigen molecules.
From a manufacturing point of view, simple
protocols with fewer steps and minimal reagent use
are desirable. Maintenance of tissue architecture,
protein and GAG content is particularly important
to decellularized tissues, since it is the structure that is
responsible for corneal transparency and
functionality.
Corneal Transparency, Light Transmittance
and Structural Integrity
To have sufficient functionality, a decellularized
cornea should ideally have low light absorption and
FIGURE 5 (A) Relative cell viability of corneal stromal cells cultured with control corneal tissues. All cells cultured with control
corneal tissue (complete, stromal and agitated) proliferated at a greater rate than the control cells cultured without corneal tissue,
although these differences were not significant. (B) Relative cell viability of corneal stromal cells cultured with decellularized corneal
tissues. Cells cultured with corneal tissue decellularized with SDS proliferated significantly less compared to the NaCl and Triton-X
decellularized tissues, and the cellular control, p 0.0001. (C) Combined analysis of cell viability with both cells cultured with control
and decellularized tissues displayed on the same graph n= 5. Data represented as the mean value ± the calculated SD.
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scattering in the visible region, while having accept-
able refractive power.14 In vivo corneal transparency
depends upon highly complex levels of organization
and regular spatial ordering of the thin collagen fibrils
within the stroma.38–40 The cornea is unique since
nanoscale tissue disruption results in macroscopic
changes, ultimately affecting transparency and light
transmission. Thus, macroscopic evaluation following
decellularization is a rudimentary method of deter-
mining if structural disruption has occurred.
The structure and composition of a biomaterial are
as important in cell signaling as growth factors,
cytokines and other mediators.33 Structural changes
following decellularization, including defects and
voids within the matrix lead to structural comprom-
ise,41 responsible for poor long-term performance
following implantation.37 NaCl decellularized corneas
yielded the most transparent tissues with least stro-
mal disruption, in agreement with previous studies.28
The exact mechanism whereby the osmotic agent
NaCl decellularizes is not fully understood, however
Gilbert et al. suggested that NaCl induces osmotic
shock, triggering cell rupture within the tissue.30 An
alternative hypothesis proposes that Na and Cl ions
capable of crossing cellular membranes extract water
from cells, modifying cell volume, thus altering the
macromolecular content, inducing cell death.42
Non-ionic detergents disrupt lipid–lipid and lipid–
protein interactions while leaving protein–protein
interactions intact; they are generally non-denaturing,
thus remaining proteins following Triton-X treatment
should retain functional conformation.43 Although
reduced transparency and collagen disruption was
observed in Triton-X treated corneas, it was not to the
extent of SDS-treated corneas. Ionic detergents,
including SDS, solubilize both cytoplasmic and
nuclear cell membranes, damaging collagen30 and
denature proteins by disrupting protein–protein
interactions.43 As a result, SDS-treated corneas had
the greatest loss of transparency with most ECM
disruption compared to all other treatments, in
agreement with other studies.22,28 This may affect
the mechanical integrity of the tissue as demon-
strated by Du et al.14 due to a denaturation of the
collagen triple helix, or loss of macromolecular
substances such as glycoproteins37; ultimately affect-
ing the tissue’s ability to withstand surgical manipu-
lation including suturing.
Interestingly, the stromal controls treated with
Dispase to remove the epithelium and endothelium
experienced reduced transparency. This may be due
to the removal of the epithelium and endothelium
damaging the basement membrane and Descemet’s
membrane respectively. However, the agitated con-
trols did not experience reduced transparency, despite
the epithelium and endothelium being absent. Thus,
prolonged mechanical agitation alone may negate the
need for the use of Dispase.
Irrespective of the decellularization treatment,
nuclease treatments caused a further loss of transpar-
ency and additional structural disruption. Earlier
studies reported a severe distortion of the collagen
structure following nuclease treatments.22 Although
the effect was not severe, structural distortion may
have been caused by the hypotonic nature of the
nuclease solutions, causing remaining cells to swell
and lyse, resulting in the voids observed in the
collagen structure.
Previous studies have demonstrated a ‘‘restor-
ation’’ of corneal transparency following submersion
in glycerol.23 The mechanism whereby glycerol causes
optical clearing is not fully understood, although
transmission electron microscopy and polarized light
microscopy studies have revealed that glycerol causes
an unraveling, dissociation and loss of organization in
the collagen fibril structure, although this is reversible
upon submersion in PBS.44 Scanning electron micros-
copy and optical coherence tomography analysis have
revealed that glycerol reduces light scattering and
causes structural modifications including increased
pore sizes.45 Thus, glycerol may mask structural
damage as a result of the decellularization procedure,
while also causing additional disorganization to the
collagen structure. Therefore, glycerol was not
included in this study.
Residual DNA
Extraction of residual cellular components is believed
to minimize immunologically induced responses that
lead to graft failure.14,46 Components of dead cells
(cytosol, cell membranes, organelles and cytoskeleton)
can also activate innate and acquired immune
responses resulting in rejection46,47; although it has
been suggested a ‘‘threshold’’ amount of material is
required to promote adverse remodeling responses
following implantation.47 Intracellular cytoplasmic
protein and membrane components are likely to be
retained within the tissue alongside residual DNA,47
although decellularizing agents may alter residual cell
products so they no longer stimulate adverse host
responses.
Detergent use alone has been reported to be
ineffective in eradicating cellular material from the
cornea,14 which corresponds with our observations, as
high amounts of DNA were detected following all
initial decellularization treatments. SDS was most
effective in removing cellular components, in agree-
ment with previous studies14; as a result of collagen
lattice disruption and increased interfibrillar spacing,
leading to an increased surface area and porosity, thus
allowing more cellular material to be released.
Conversely, the relative conservation of the dense
collagen network following all other decellularization
treatments, although may have led to cell lysis and
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apoptosis, did not sufficiently allow DNA release
from the tissue.
Nucleases including endonucleases utilized in this
study, catalyze the hydrolysis of interior bonds in the
ribonucleotide or deoxyribonucleotide chains; cleav-
age mid-sequence leads to DNA fragmentation and
degradation30 enabling easier removal from the tissue.
Nuclease treatment significantly reduced DNA,
although was more successful in corneas pre-treated
with decellularizing agents. This result is rational
since the ECM needs to be adequately disrupted to
allow cells exposure to nucleases, while providing a
path for removal of cellular material.30 Stromal con-
trols had significantly lower DNA following nuclease
treatment, potentially due to the removal of the
epithelium and endothelium disrupting/damaging
the barrier function of the basement membrane
and/or the Descemet’s membrane, allowing a higher
efficacy of DNA removal following nuclease cleavage.
Collagen and sGAG Content as a Marker of
the Stripping Effects of Decellularization
Protocols
The effect of cell extraction on corneal ECM proteins
has not been studied extensively.14 The majority of the
stroma is comprised of collagen I, V, VI and XII, along
with dermatan sulfate proteoglycan decorin and
keratan sulfate proteoglycans lumican, keratocan,
osteoglycin (mimican)48,49 and small amounts of
heparin50 forming the ground substances of the
stroma, responsible for the spatial distribution and
organization of the collagen fibrils,38,51 assembly and
fibrillogenesis.50 GAGs also bind growth factors and
cytokines, promote water retention and contribute to
the gel properties of the ECM.52 Thus, any alteration/
reduction in GAG-content in decellularized corneas
may affect the tissue bioactivity.
Previous studies on numerous tissues have demon-
strated that despite structural disruption and reduced
cellular and GAG content, collagen content is not
affected by decellularizing reagents.33,53–55
Quantification of collagen following the different
decellularization protocols agreed with these studies.
It was observed in control corneas that KS-GAG
expression manifested as thin, fibrillar streaks
between collagen fibers, as previously observed.50
Following decellularization, KS-GAG expression was
reduced as previously reported.36 Perhaps more
importantly, remaining KS-GAGs distribution was
disrupted.
Mendoza-Novelo et al. suggested that sGAG
removal is influenced not only by the type of
decellularization reagent used, but also the swelling
behavior of the tissue.36 Since SDS-treated corneas
experienced greatest collagen disruption, interfibrillar
spacing and ultimately increased swelling, observed
subjectively, more GAGs could be released compared
to Triton-X-treated tissues. Similar results were
observed33 whereby tissues treated with mild non-
ionic detergents removed free-GAGs, whereas those
treated with strong ionic detergents caused additional
dissociation of proteoglycans bound to the collagen
fibrils.
Scaffold Biocompatibility
Proliferation studies were utilized as a rudimentary
indicator of the biocompatibility of the decellularized
scaffolds. All cells cultured with control tissues
proliferated more than cells cultured with decellular-
ized tissue. Improved cell growth may have occurred
for a number of reasons: (i) the intrinsic, biological
cues including GAGs, remaining within the structure
of untreated tissues had a favorable stimulatory effect
on proliferation; a hypothesis supported by previous
work by Gratzer et al.56 It was observed that cells
cultured in the presence of decellularized tissues,
whereby structural disruption and GAGs had dimin-
ished, proliferation was significantly reduced. (ii)
Residual decellularizing agents were detrimentally
effecting cell growth and proliferation. SDS in par-
ticular, is notoriously difficult to eradicate following
decellularization and residual detergent is thought to
have cytotoxic effects as it leaches from the tissue.37,57
Conversely, cellular material remaining in control
tissues may have detrimentally affected proliferation.
Extensive studies have demonstrated that the healthy
corneal stromal cell phenotype, the keratocyte, is
quiescent.34,58–66 A proliferative CSC, the fibroblast or
myofibroblast, would indicate an inflammatory
response resulting in an activation of the CSC into
an injury phenotype.34,58,61,62,67–70 However, we
believe this effect is superseded by the fact that cells
were cultured in serum-containing media, known to
initiate CSC activation and proliferation.34,48,64 In this
instance, reduced proliferation was indicative of an
ineffective decellularization procedure.
CONCLUSION
The ability to utilize, reprocess and regenerate tissue
‘‘unsuitable’’ for transplantation allows us to salvage
valuable tissue. Reprocessing tissue has the potential
to have considerable impact on addressing donor
shortages. Recently, standard corneal treatments have
shifted from complete transplantation to procedures
that replace the diseased or injured area.22
Decellularized tissues may potentially be utilized in
partial-thickness lamellar keratoplasty procedures in
patients who have stromal opacities, while retaining a
healthy endothelium. Patients would benefit directly
by accessing greater numbers of corneal grafts, while
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health authorities would fulfill their responsibility to
deliver effective corneal reconstruction to alleviate
corneal blindness.
Ultimately, due to the way cells are embedded
within tissue ECM, especially dense corneal tissue, it
is extremely unlikely that any decellularization tech-
nique will successfully remove 100% of cellular
components.47 Most commercially available ‘‘decellu-
larized’’ scaffolds contain small amounts of remnant
DNA.47 However, even the most effective decellular-
ization method is unsuitable if it prevents subsequent
cellular repopulation33 due to matrix disruption and
residual chemicals. Since the stroma is sparsely
populated with ‘‘immune privileged’’ keratocytes,11,12
complete eradication of cellular material may not
necessarily be most appropriate, and may provoke an
immune response in the resulting tissue due to the
dispersion and incomplete removal of keratocyte
debris.
The decellularization protocol may be harmful to
the function of the biomaterial if structural integrity is
greatly compromised.33 This may warrant a change
from ‘‘traditional’’, often laborious, decellularization
procedures reliant upon extensive use of reagents and
washing steps, which ultimately are not up-scalable
from a manufacturing point of view. Since the prolif-
eration studies demonstrated that residual CSC did
not adversely affect proliferation; and tissue rejection
following corneal allografting is predominantly
caused by epithelial and endothelial rejection,71 it
may be plausible to simply remove the epithelium
and endothelium. Since agitation alone was sufficient
in removing these layers, with minimal disruption to
the stroma, transparency and GAG content, thus
maintaining tissue functionality with an intact base-
ment and Descemet’s membrane; agitation alone will
be further investigated as a potential technique for
recycling corneal tissue. The remaining ‘‘immune
privileged’’ keratocytes would remain intact, with
no fragmented DNA, residual artifacts or antigen
molecules. This technique would also negate the need
for further studies to assess the removal of residual
chemicals from the tissue as they may have cytotoxic
effects, while also inhibiting cell adhesion, migration
and proliferation,41 leading to tissue rejection.22
Although the complete removal of any antibiotic/
antimycotic agents needs to be ensured so that the
construct is not considered a medical device by
regulatory bodies.
Additional transmission electron microscopy (TEM)
would be beneficial in analyzing the ultrastructure of
the corneal stroma following decellularization. This
would allow for the orientation of collagen fibrils and
disruption to the highly organized architecture follow-
ing decellularization to be examined and compared to
the native cornea. The extent to which the typical
orthogonal arrangement of fibril bands and tightly
packed lamellae is disrupted following
decellularization could be used to determine if such
changes have an impact on scaffold biocompatibility
and remodeling following recellularization.
Although there are still many challenges to address
prior to clinical translation, the ‘‘recycling’’ of unsuit-
able tissues still represents a promising alternative to
cadaveric tissue. However, in order to progress, we
may need to take a step back to establish a
‘‘decellularization’’ criterion; which should balance
effective removal of immune reactive material with
maintenance of tissue functionality; along with the
development of appropriate, systematic and standar-
dized screening protocols.
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